Integrated Analysis of Mutations, miRNA and mRNA Expression in Glioblastoma

References

• Nagaraja S, Vitanza NA, Woo PJ, et al. Transcriptional dependencies in diffuse intrinsic pontine glioma. Cancer Cell. 2017;31:635–652.e6.
   PubMed Web of Science ®Google Scholar
• Shergalis A, Bankhead A 3rd, Luesakul U, et al. Current challenges and opportunities in treating glioblastoma. Pharmacol Rev. 2018;70:412–445.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Gittleman H, Liao P, et al. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol. 2017;19:v1–v88.
   PubMed Web of Science ®Google Scholar
• Lim KY, Won JK, Park CK, et al. H3 G34-mutant high-grade glioma. Brain Tumor Pathol. 2021;38:4–13.
   PubMed Web of Science ®Google Scholar
• Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11:252–263.
   PubMed Web of Science ®Google Scholar
• Que T, Song Y, Liu Z, et al. Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1. Oncogene. 2015;34:4952–4963.
   PubMed Web of Science ®Google Scholar
• Hu N, Zhang J, Cui W, et al. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. J Biol Chem. 2011;286:13714–13722.
   PubMed Web of Science ®Google Scholar
• LeBlanc VC, Morin P. Exploring miRNA-associated signatures with diagnostic relevance in glioblastoma multiforme and breast cancer patients. J Clin Med. 2015;4:1612–1630.
   PubMed Web of Science ®Google Scholar
• Chiosea S, Jelezcova E, Chandran U, et al. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol. 2006;169:1812–1820.
   PubMed Web of Science ®Google Scholar
• Deng B, Wang M, Liu Z. A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer. Medicine (Baltimore). 2020;99:e22261.
   PubMed Web of Science ®Google Scholar
• Rezaei O, Honarmand K, Nateghinia S, et al. miRNA signature in glioblastoma: potential biomarkers and therapeutic targets. Exp Mol Pathol. 2020;117:104550.
   PubMed Web of Science ®Google Scholar
• Behjati S, Tarpey PS. What is next generation sequencing?. Arch Dis Child Educ Pract Ed 2013;98:236–238.
   PubMed Web of Science ®Google Scholar
• Manicum T, Ni F, Ye Y, et al. Prognostic values of E2F mRNA expression in human gastric cancer. Biosci Rep. 2018;38:BSR20181264.
   PubMed Web of Science ®Google Scholar
• Xue VW, Cheung MT, Chan PT, et al. Non-invasive potential circulating mRNA markers for colorectal adenoma using targeted sequencing. Sci Rep. 2019;9:12943.
   PubMed Web of Science ®Google Scholar
• Liu G, Pan Y, Li Y, et al. lncRNA and mRNA signature for prognosis prediction of glioblastoma. Future Oncol. 2020;16:837–848.
   PubMed Web of Science ®Google Scholar
• Jiang T, Nam DH, Ram Z, et al. Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2021;499:60–72.
   PubMed Web of Science ®Google Scholar
• Denaro N, Russi EG, Merlano MC. Pros and cons of the new edition of TNM classification of head and neck squamous cell carcinoma. Oncology. 2018;95:202–210.
   PubMed Web of Science ®Google Scholar
• Paner GP, Stadler WM, Hansel DE, et al. Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol. 2018;73:560–569.
   PubMed Web of Science ®Google Scholar
• Trapnell C, Williams BA, Pertea G, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511–515.
   PubMed Web of Science ®Google Scholar
• Frazee AC, Pertea G, Jaffe AE, et al. Ballgown bridges the gap between transcriptome assembly and expression analysis. Nat Biotechnol. 2015;33:243–246.
   PubMed Web of Science ®Google Scholar
• Young MD, Wakefield MJ, Smyth GK, et al. Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol. 2010;11:R14.
   PubMed Web of Science ®Google Scholar
• Mao X, Cai T, Olyarchuk JG, et al. Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics. 2005;21:3787–3793.
   PubMed Web of Science ®Google Scholar
• Sjodahl G, Eriksson P, Liedberg F, et al. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification. J Pathol. 2017;242:113–125.
   PubMed Web of Science ®Google Scholar
• Girardi D, Barrichello A, Fernandes G, et al. Targeting the Hedgehog pathway in cancer: current evidence and future perspectives. Cells. 2019;8:135.
   PubMed Web of Science ®Google Scholar
• Agren M, Kogerman P, Kleman MI, et al. Expression of the PTCH1 tumor suppressor gene is regulated by alternative promoters and a single functional Gli-binding site. Gene. 2004;330:101–114.
   PubMed Web of Science ®Google Scholar
• Wang M, Dong Q, Wang Y. Rab23 is overexpressed in human astrocytoma and promotes cell migration and invasion through regulation of Rac1. Tumour Biol. 2016;37:11049–11055.
   PubMedGoogle Scholar
• Chiang J, Li X, Liu APY, et al. Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations. Acta Neuropathol. 2020;139:601–602.
   PubMed Web of Science ®Google Scholar
• Chen X, Hao A, Li X, et al. Activation of JNK and p38 MAPK mediated by ZDHHC17 drives glioblastoma multiforme development and malignant progression. Theranostics. 2020;10:998–1015.
   PubMed Web of Science ®Google Scholar
• Dong J, Liu Y, Hao Y, et al. Expression and correlation of Rab23 with pathological grades in human glioma cells. J Biol Regul Homeost Agents. 2019;33:1885–1889.
   PubMed Web of Science ®Google Scholar
• Ryall S, Tabori U, Hawkins C. Pediatric low-grade glioma in the era of molecular diagnostics. Acta Neuropathol Commun. 2020;8:30.
   PubMed Web of Science ®Google Scholar
• Nitta Y, Miyachi M, Tomida A, et al. Identification of a novel BOC-PLAG1 fusion gene in a case of lipoblastoma. Biochem Biophys Res Commun. 2019;512:49–52.
   PubMed Web of Science ®Google Scholar
• Jiang C, Qu X, Ke H, et al. Association between the HMGB1/TLR4 signaling pathway and the clinicopathological features of ovarian cancer. Mol Med Rep. 2018;18:3093–3098.
   PubMed Web of Science ®Google Scholar
• Zheng S, Tao W. Identification of novel transcriptome signature as a potential prognostic biomarker for anti-angiogenic therapy in glioblastoma multiforme. Cancers (Basel). 2020;12:2368.
   PubMedGoogle Scholar
• Sun Z, Shi K, Yang S, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17:147.
   PubMed Web of Science ®Google Scholar
• Xu B, Liu J, Xiang X, et al. Expression of miRNA-143 in pancreatic cancer and its clinical significance. Cancer Biother Radiopharm. 2018;33:373–379.
   PubMed Web of Science ®Google Scholar
• Zhang B, Pan X, Cobb GP, et al. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1–12.
   PubMed Web of Science ®Google Scholar
• Kunz M, Brandl M, Bhattacharya A, et al. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma. J Nanobiotechnology. 2020;18:173.
   PubMed Web of Science ®Google Scholar
• Magalhaes L, Quintana LG, Lopes DCF, et al. APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes. BMC Cancer. 2018;18:1055.
   PubMed Web of Science ®Google Scholar
• Liu X, He M, Hou Y, et al. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma. Oncol Rep. 2013;29:1415–1420.
   PubMed Web of Science ®Google Scholar
• Schuller M, Jenne D, Voltz R. The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease. J Neuroimmunol. 2005;169:172–176.
   PubMed Web of Science ®Google Scholar
• Li H, Liu J, Shen S, et al. Pan‐cancer analysis of alternative splicing regulator heterogeneous nuclear ribonucleoproteins (hnRNPs) family and their prognostic potential. J Cell Mol Med. 2020;24:11111–11119.
   PubMed Web of Science ®Google Scholar
• Guan Y, Mizoguchi M, Yoshimoto K, et al. MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. Clin Cancer Res. 2010;16:4289–4297.
   PubMed Web of Science ®Google Scholar
• Roy B, Dunbar M, Agrawal J, et al. Amygdala-based altered mirnome and epigenetic contribution of miR-128-3p in conferring susceptibility to depression-like behavior via Wnt signaling. Int J Neuropsychopharmacol. 2020;23:165–177.
   PubMed Web of Science ®Google Scholar